NEW YORK, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of DBV Technologies (Nasdaq:DBVT), a clinical-stage specialty biopharmaceutical company, commenced on The Nasdaq Stock Market on October 22, 2014.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=28541
Headquartered in Bagneux, France, DBV Technologies is a biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin®. The company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT®, a proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. DBV Technologies is focusing on severe food allergies, including milk and peanut, for which there are currently no effective treatments. DBV Technologies was incorporated in 2002.
"As allergies become increasingly prevalent as a major health issue, DBV Technologies continues to evolve and innovate in this field," said Adam Kostyál, Senior Vice President, Listing Services, Nasdaq. "We are proud to have DBV Technologies listed on The Nasdaq Stock Market."
By listing with Nasdaq, DBV Technologies joins many of the world's largest and most revolutionary companies. Nasdaq has been the exchange of choice to 93 percent of healthcare companies listed in the U.S. markets.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.
The photo is also available via AP PhotoExpress.
CONTACT: Media Relations Contacts: Will Briganti (646) 441-5012 email@example.com Christine Barna (646) 441-5310 Christine.Barna@nasdaq.com
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.